Last Updated : August 5, 2025
Details
FilesGeneric Name:
naloxegol
Project Status:
Complete
Therapeutic Area:
Management of opioid-induced constipation (OIC).
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0753-000
Call for patient/clinician input closed:
NOC Status at Filing:
N/A
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Submission Complexity:
Standard Review
Fee Schedule:
Pending
Indications:
Treatment of opioid-induced constipation (OIC) in adult patients with cancer and non-cancer pain who have had an inadequate response to laxative(s).
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation/Report:
| Submission received | November 22, 2024 |
|---|---|
| Expert committee meeting (initial) | May 15, 2025 |
| Draft recommendation posted for stakeholder feedback | June 02, 2025 |
| End of feedback period | June 16, 2025 |
| Final recommendation posted | July 17, 2025 |
| CDA-AMC review report(s) posted | July 30, 2025 |
Files
Last Updated : August 5, 2025